These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 209883)

  • 1. The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats.
    Taper HS
    Cancer; 1978 Aug; 42(2):462-7. PubMed ID: 209883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemical correlation between glycogen, nucleic acids and nucleases in pre-neoplastic and neoplastic lesions of rat liver after short-term administration of N-nitrosomorpholine.
    Taper HS; Bannasch P
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Sep; 87(1):53-65. PubMed ID: 185826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoplastic and preneoplastic lesions in rats after oral administration of a single dose of N-nitrosomorpholine (author's transl)].
    Bannasch P; Mayer D; Krech R
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):233-48. PubMed ID: 479263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine.
    Moore MA; Mayer D; Bannasch P
    Carcinogenesis; 1982; 3(12):1429-36. PubMed ID: 7151256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogens as promoters of hepatic neoplasia.
    Wanless IR; Medline A
    Lab Invest; 1982 Mar; 46(3):313-20. PubMed ID: 6278220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone.
    Metzger C; Bannasch P; Mayer D
    Cancer Lett; 1997 Dec; 121(2):125-31. PubMed ID: 9570349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of rat liver carcinogenicity of 4-nitrosomorpholine by alpha-deuterium substitution.
    Lijinsky W; Taylor HW; Keefer LK
    J Natl Cancer Inst; 1976 Dec; 57(6):1311-3. PubMed ID: 187800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.
    Weber E; Bannasch P
    Carcinogenesis; 1994 Jun; 15(6):1235-42. PubMed ID: 8020161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
    National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
    Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis.
    Ito N; Moore MA; Bannasch P
    Carcinogenesis; 1984 Mar; 5(3):335-42. PubMed ID: 6705139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of hepatocarcinogenesis in rats by dietary fructose.
    Enzmann H; Ohlhauser D; Dettler T; Bannasch P
    Carcinogenesis; 1989 Jul; 10(7):1247-52. PubMed ID: 2567639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oral contraceptive agents in the pathogenesis of liver tumors.
    Nissen ED; Kent DR; Nissen SE
    J Toxicol Environ Health; 1979; 5(2-3):231-54. PubMed ID: 224197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumorigenicity of TTT dissolved in DMSO (author's transl)].
    Urban H; Danz M
    Arch Geschwulstforsch; 1976; 46(8):657-62. PubMed ID: 190974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo electroporetic transfer of bcl-2 antisense oligonucleotide inhibits the development of hepatocellular carcinoma in rats.
    Baba M; Iishi H; Tatsuta M
    Int J Cancer; 2000 Jan; 85(2):260-6. PubMed ID: 10629087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.
    Solt DB; Medline A; Farber E
    Am J Pathol; 1977 Sep; 88(3):595-618. PubMed ID: 18937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenesis in rats by some hydroxylated acyclic nitrosamines.
    Lijinsky W; Saavedra JE; Reuber MD
    Carcinogenesis; 1984 Feb; 5(2):167-70. PubMed ID: 6697433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxin N-nitrosomorpholine-induced carcinogenesis in rat liver: ex vivo exploration of preneoplastic and neoplastic hepatocytes.
    Jeong JS; Lee SH; Jung KJ; Choi YC; Park WY; Kim IH; Kim SS
    Exp Mol Pathol; 2003 Feb; 74(1):74-83. PubMed ID: 12645635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats.
    Lijinsky W; Kovatch RM; Riggs CW; Walters PT
    Cancer Res; 1988 Apr; 48(8):2089-95. PubMed ID: 3349480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.